THEMIS MEDICARE LTD. - 530199 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot
Please find attached Outcome of business(es) conducted via Postal Ballot Notice dated 7th September, 202316-11-2023
16-11-2023
THEMIS MEDICARE LTD. - 530199 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Please find attached Scrutinzer''s Report along with Voting Results for the business(es) conducted via Postal Ballot Notice dated 7th September, 202316-11-2023
THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
With reference to the captioned matter, please find our intimation along with Press Release10-11-2023
THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Please find our intimation on the captioned matter08-11-2023
THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Please find our intimation on the captioned subject.06-11-2023
THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find our intimation on the captioned subject and for publication of unaudited financial statements for the quarter and half year ended 30th September 202306-11-2023
THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find our intimation on the captioned subject04-11-2023
THEMIS MEDICARE LTD. - 530199 - Financial Results For The Quarter And Half-Year Ended 30Th September 2023
Please find enclosed financial results for the quarter and half-year ended 30th September 202304-11-2023
THEMIS MEDICARE LTD. - 530199 - Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
Pursuant to Regulation 30 of the Listing Regulations, this is to inform you that the Board of Directors of the Company, at its meeting held today i.e. on Saturday, 4th November, 2023, has inter-alia approved the following: a) The Unaudited Standalone and Consolidated Financial Results for the Quarter and Half year ended 30th September, 2023. A copy of Unaudited Standalone and Consolidated Financial Results for the Quarter and Half year ended 30th September, 2023 together with Limited Review Report issued by M/s. Krishaan & Co., Chartered Accountants is enclosed herewith. b) The proposal to enter into Master Service Agreement with its Related Party and Associate Company, viz. Gujarat Themis Biosyn Limited. The details required as per SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 read with Regulation 30A of the Listing Regulations are enclosed as Annexure - I. This may be taken as compliance under the Listing Regulations.04-11-2023
THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Please find our intimation on the captioned matter31-10-2023